Quanyin Hu, Ph.D.
Pharmaceutical Sciences Division
School of Pharmacy
UW Carbone Cancer Center
School of Medicine and Public Health
University of Wisconsin-Madison
Prof. Hu received his Ph.D. degree in Biomedical Engineering from the University of North Carolina at Chapel Hill and North Carolina State University under the supervision of Prof. Zhen Gu in 2018. From 2018-2020, he was a postdoc associate in the laboratory of Prof. Robert Langer in Koch Institute for Integrative Cancer Research at MIT. Prof. Hu joined UW-Madison in 2020 as an assistant professor in the Pharmaceutical Sciences Division at the School of Pharmacy.
Welcome to Hu CIPT lab at UW-Madison! The ultimate goal of our laboratory is to leverage the delivery approach to address current clinical challenges and facilitate translational research by combining cell therapy, immunotherapy, and personalized therapy. Specifically, by adopting the concept of “CIPT”, we are getting inspiration from natural cells to design our delivery tools and particularly interested in engineering cells and cell derivatives as vehicles for delivery of small/macromolecules, proteins, and antibodies to treat a broad array of diseases, including cancer, infectious disease, and autoimmune disease. We are also leveraging the interaction between synthetic materials and immune cells to modulate the immune response in a controllable fashion. To advance personalized therapy, neoantigen-based vaccination and microbiota research will be emphasized in our lab to transform traditional “one-size-fits-all” treatment to precision medicine for each individual.
Apr. 2022: Our review paper was accepted for publication in Journal of Materials Chemistry B!
Mar. 2022: Our research paper was accepted for publication in Nature Communications!
Jan. 2022: Our review paper was accepted for publication in Advanced Functional Materials!
Jan. 2022: Our lab was awarded The 2022 UWCCC Pancreas Cancer Research Task Force Investigator Initiated Project Award!
Jan. 2022: Our review paper was accepted for publication in Exploration!
Jan. 2022: Dr. Hu was selected for 2021 Journal of Nanobiotechnology Outstanding Editor Award!
Dec. 2021:Our lab was awarded a Pandemic-Affected Research Continuation Initiative Award from VCRGE!
Nov. 2021: Dr. Hu was invited to contribute a review article in Expert Opinion on Drug Delivery!
Nov. 2021: Our probiotics technology was selected as one of six finalists for competing for the WARF Annual Innovation Award!
Nov. 2021: Dr. Hu was selected as one of 2022 Emerging Investigators for Journal of Materials Chemistry B!
Oct. 2021: Our lab has been awarded a UWCCC Transdisciplinary Cancer Immunology-Immunotherapy Pilot Award!
Sep. 2021: Our very first research article has been accepted for publication in Nano Today!
Aug. 2021: Our Opinion review paper has been accepted for publication in Nano Today!
July. 2021: Our invited review paper has been accepted for publication in Advanced Drug Delivery Reviews!
June. 2021: Dr. Hu has been invited to serve as a Young Star Editor for Nano Research (IF=8.897)!
May. 2021: Our review paper has been accepted for publication in Advanced Materials!
May. 2021: Tina has been awarded Thomas & Bonnie Minter Graduate Student Cancer Research Award!
May. 2021: Our lab was invited to contribute a manuscript to Wiley's new journal - Exploration!
Apr. 2021: Our paper has been published on Nature Biomedical Engineering and featured by UW-Madison News! Read more
Apr. 2021: Our lab has been awarded CCSG grant from UWCCC!
Mar. 2021: Our review paper has been accepted for publication in Nano Today!
Mar. 2021: Our paper has been accepted for publication in Nature Biomedical Engineering!
Feb. 2021: Our very first review paper has been accepted for publication in Advanced Functional Materials!
Dec. 2020: Dr. Hu has been invited to serve as an Associated Editor for Journal of Nanobiotechnology (Springer Nature, IF=10.435)!
Oct. 2020: Dr. Liu and Tina joined CIPT lab!
July 2020: Hu CIPT lab officially opens!!!